Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. andchanged its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.

Biotechnology

Clinical Trials

Health Diagnostics

Therapeutics

Visterra Inc.

Brian J.G. Pereira

Mary King Newton-Gruswitz

David Oldach

Zachary Shriver

William C. Tubbs

Jill Yarbrough

Marcia Heron

Jonathan Lonczak

Chris Kiefer

Todd Curtis

Jean Bender

The Research and Development team at Visterra Inc. focuses on the discovery, design, and advancement of therapeutic and diagnostic products targeting infectious diseases. Utilizing their expertise in glycobiology and glycochemistry, they develop innovative structure-based therapeutic and diagnostic platforms to address unmet medical needs. The team comprises experienced professionals, including senior directors and vice presidents, who lead efforts in pharmaceutical sciences, nonclinical development, regulatory affairs, and research.

Research and Development

Leadership Team

Research and Development

About

Team members

Other teams at Visterra Inc.

Research and Development

Leadership Team